Gemfibrozil Tablet
Product Images NDC 70771-1431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 70771-1431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 01)

FDA Label Image

Label (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 02)

Label (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 02)
Each tablet of NDC 70771-1431-3 contains 600mg of gemfibrozil as per USP standards. The standard dosage information can be found in the package insert, which includes complete prescribing details. The tablets should be stored in a container that is resistant to light and humidity at a temperature of 20° to 25°C (68° to 77°F) which is the controlled room temperature mentioned in USP. It also mentions to keep this medicine away from children. The manufacturer of this medicine is A Calila Healthcare Ltd. and it is a prescription drug available in a pack of 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.